Nocebo Hypothesis Cognitive Behavioural Therapy (NH-CBT) for Functional Neurological Disorder (FND)

9:00 AM
-
4:30 PM

twofiftyseven, level 2 / 57 willis street Wellington

This workshop represents a basic training in using NH-CBT clinically. Participants will learn how to treat functional symptoms of weakness, fixed dystonia, imbalance/dizziness, tremors, tics, and non-epileptic seizures. They will also learn a basic overview of predictive coding models and nocebo effects, in order to help them field the inevitable questions about causation of FND that they will be asked in clinical practice.
NZPsS Member: $245 (Zoom only $180); Non-Members $295 (Zoom only $230)
This event will be livestreamed - there will be NO RECORDING available.

NH-CBT is the name given to a treatment protocol developed over 12 years ago by Dr Matt Richardson, following some successful experimentation with a client with functional neurological symptoms. The treatment protocol achieved complete or almost complete symptom resolution in 12 of the next 13 patients, usually within 2 weeks. That case series was published in 2018, and helped attract funding for a randomized controlled trial. This has now been completed (although not published yet), and saw 85% of intervention group participants reach full symptom resolution, with significant differences in rate of full recovery, reduction of observable functional symptoms, and reduction of mobility aid use when compared to an active control treatment. The theoretical basis for the treatment itself is consistent with contemporary predictive coding models of FND, in that it treats FND as if it is a self-perpetuating and sometimes extreme version of a nocebo effect.

This workshop represents a basic training in using NH-CBT clinically. Participants will learn how to treat functional symptoms of weakness, fixed dystonia, imbalance/dizziness, tremors, tics, and non-epileptic seizures. They will also learn a basic overview of predictive coding models and nocebo effects, in order to help them field the inevitable questions about causation of FND that they will be asked in clinical practice.

This workshop is suitable for Clinical Psychologists, Neuropsychologists, Physiotherapists, Occupational Therapists and Rehabilitation Nurses  who treat people with FND. 

Speech and Language Therapists are also welcome, although this initial workshop will not include any specific training about functional speech and swallowing issues. This, as well as other less core aspects of FND treatment, will be covered in online modules that will be developed and made available in the future.

Outcomes

Participants will:

  • be able to fully practice NH-CBT with people with functional neurological symptoms
  • understand the basic ideas regarding the evidence that functional neurological symptoms are the result of a nocebo effect
  • develop some ideas about how this hypothesis might influence their practice with all patients / clients with neurological damage or disease


PRESENTER: DR MATT RICHARDSON

Dr Matt Richardson is a clinical psychologist / neuropsychologist who predominantly works at the Puāwai Rehabilitation Unit at Wakari Hospital, Dunedin, New Zealand (a regional neurorehabilitation service).

He was born and trained in the UK, gaining his Bachelor’s degree from the University of St Andrews (Scotland), and his clinical doctorate at University College London. He moved to New Zealand in 2008, and soon started working clinically with patients with functional neurological symptoms for the first time. He quickly became disenchanted with traditional theories of FND, that implicated psychological trauma and stress as the core causative factor, and devised a novel treatment in 2011, now named Nocebo Hypothesis Cognitive Behavioural Therapy (NH-CBT). He went on to publish an initial consecutive case series, which achieved 93% full remission of a range of functional neurological symptoms, and has now completed a randomised controlled trial of NH-CBT for functional motor symptoms that saw 85% of people in the intervention condition achieving full symptom remission, with large treatment effect sizes on the majority of measures. He also completed a pilot consecutive case series in the use of NH-CBT for the treatment of non-epileptic / functional seizures, with all participants with daytime seizures who completed the treatment becoming seizure-free at the end of the treatment period.

He has been training others in his treatment protocol across Australasia since 2018. This has included a workshop at the Australian College of Clinical Neuropsychologists’ annual conference in 2018, and an invitation to speak at the 2019 Neurologists’ Association of New Zealand annual meeting, as well as workshops in all major New Zealand cities.

He also practices sports psychology, and has worked with New Zealand #1’s in two different sports.